COP News 82.50 08/01/2014 04:49:52 Conocophillips (COP)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Conocophillips (COP) 82.50 $COP

ConocoPhillips'
at Investor's Business Daily - Thu Jul 31, 5:53PM CDT
ConocoPhillips' (COP) Q2 EPS leapt 14% to $1.61, beating views by 1 cent. Oil and natgas output rose 3.3% to 1.56 mil barrels oil equivalent per day. The energy giant sees Q3 production falling on maintenance. Shares fell 2.5% to 82.50.

SmarTrend Watching for Potential Rebound in Shares of ConocoPhillips After 2.52% Loss
Comtex SmarTrend(R) - Thu Jul 31, 4:50PM CDT
ConocoPhillips (NYSE:COP) traded in a range yesterday that spanned from a low of $82.37 to a high of $84.56. Yesterday, the shares fell 2.5%, which took the trading range below the 3-day low of $84.11 on volume of 7.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Occidental Petroleum Beats Q2 Earnings and Revenue Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 31, 4:20PM CDT
In second-quarter 2014, Occidental Petroleum Corporation's (OXY) earnings per share and revenues surpassed the Zacks Consensus Estimate.

Apache Eyes Overseas Exit As Jana Urges U.S. Focus
at Investor's Business Daily - Thu Jul 31, 1:58PM CDT
Apache (APA) decided to divest some international assets, and may unload more, after a large shareholder urged the oil and gas company to focus on U.S. shale plays. In an earnings release Thursday, Apache said that it intends to exit the Wheatstone...

Jobs, Manufacturing Hurt Stocks; 3D Systems, KapStone Slide
at Investor's Business Daily - Thu Jul 31, 9:28AM CDT
Stocks buckled early Thursday under a heavy load of disappointing economic news. The Nasdaq axed off 1.1%. The S&P 500 dumped 1% and the Dow Jones industrial average dropped 0.9%, as nearly a third of its components shed 1% or more. A wave of early...

Alphabet Soup: GDP, ECB, QE and Q2 - Ahead of Wall Street
Sheraz Mian - ZACKS - Thu Jul 31, 9:12AM CDT
Including this morning's releases from Exxon (XOM), ConocoPhillips (COP) and others, we now have Q2 results from 358 S&P 500 members.

ConocoPhillips Q2 Earnings Beat on Higher Prices and Volume - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jul 31, 8:16AM CDT
ConocoPhillips (COP) reported second-quarter 2014 adjusted earnings of $1.61 per share, surpassing the Zacks Consensus Estimate of $1.60 per share and increasing 14.2% from the year-earlier profit of $1.41.

ConocoPhillips 2Q profit rises 1.5 percent
AP - Thu Jul 31, 8:05AM CDT
HOUSTON (AP) — ConocoPhillips (COP) on Thursday reported net income that increased by 1.5 percent in its second quarter. The results beat analysts' expectations.

ConocoPhillips Reports Second-Quarter 2014 Results; Strong Operational Performance
Business Wire - Thu Jul 31, 6:01AM CDT
ConocoPhillips (NYSE:COP) today reported second-quarter 2014 earnings of $2.1 billion, or $1.67 per share, compared with second-quarter 2013 earnings of $2.1 billion, or $1.65 per share. Excluding special items, second-quarter 2014 adjusted earnings were $2.0 billion, or $1.61 per share, compared with second-quarter 2013 adjusted earnings of $1.8 billion, or $1.41 per share. Special items for the current quarter primarily related to additional income associated with pending claims and settlements, partially offset by leasehold impairments in the Canadian arctic.

Jim Cramer's 'Mad Money' Recap: Thinking 5 Steps Ahead and Being Wrong
at The Street - Wed Jul 30, 6:55PM CDT
There are five groups of investors fighting over the direction of the markets, making for a confusing jumble of cross-currents, Cramer says.

Will Microchip (MCHP) Surprise on Q1 Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 30, 5:10PM CDT
Microchip Technology, Inc (MCHP) is scheduled to report first-quarter fiscal 2015 results after the closing bell on Jul 31.

Is ConocoPhillips (COP) Poised to Beat Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 30, 3:25PM CDT
We expect ConocoPhillips (COP) to beat expectations when it reports second-quarter 2014 financial results before the opening bell on Jul 31, 2014.

Hess Corporation Q2 Earnings Beat on Higher Prices, Down Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jul 30, 2:40PM CDT
Hess Corporation (HES) reported adjusted second-quarter 2014 earnings of $1.38 per share, breezing past the Zacks Consensus Estimate of $1.20.

Valero Tops As Volume Rises, Phillips 66 Misses
at Investor's Business Daily - Wed Jul 30, 11:47AM CDT
Valero Energy's (VLO) second quarter beat estimates as refining throughput volumes increased on discounted crude on the Gulf Coast. The refiner's Q2 earnings rose 27% to $1.22 per share, in line with an earlier announcement. Analysts polled by...

Early Glance: Oil companies
AP - Wed Jul 30, 9:42AM CDT
NEW YORK (AP) — Shares of some top oil companies are mixed at 10 a.m.:

Oando Energy Resources Completes Landmark Acquisition of ConocoPhillips Nigerian Oil and Gas Business for US$1.5 Billion
PR Newswire Europe - Wed Jul 30, 9:16AM CDT
CALGARY, Alberta, July 30, 2014 /PRNewswire/ --

Oando Energy Resources completes landmark acquisition of ConocoPhillips Nigerian oil and gas business for US$1.5 billion
CNW Group - Wed Jul 30, 8:00AM CDT
Oando Energy Resources Inc. ("OER" or the "Company" (TSX: OER), a company focused on oil and gas exploration and production in Nigeria, today announced the completion of its acquisition of the Nigerian Upstream Oil and Gas Business of ConocoPhillips (NYSE: COP) for a total cash consideration of US$1.5 billion after customary adjustments plus a deferred consideration of US$33 million (the "Transaction".

Should You Buy ConocoPhillips (COP) Ahead of Earnings? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jul 30, 7:28AM CDT
ConocoPhillips could beat earnings estimates this season backed by favorable earnings estimate revision activity
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Voltage Energy's Microgrid Launches at RE+ 2026

Updated Category News Views 147

Voltage Energy Unveils New Power Systems In the swirling chaos of energy innovation, Voltage Energy is trying to carve its path at the heart of RE+ 2026. Out in Las Vegas, amidst the buzz of renewable energy tech, they introduced their Microgrid System (MGS) along with two new electrical balance of system (EBOS) products—the Load Break Disconnect Box (LBD) and Combiner...

Continue Reading
CD Rates Offer Stillness as Stocks and Gold Wobble

Updated Category News Views 59

November has delivered the sort of tape that makes a supposedly diversified portfolio feel like a leaky boat. Stocks fell sharply, gold slid to a one-year low after record highs as recently as January, and Treasuries have not provided the dependable ballast many investors expected. When inflation worries and federal-debt concerns shove yields higher, bond prices can drop...

Continue Reading
Iberostar's Grand Move: Opening in Zanzibar

Updated Category News Views 114

The Resort That Takes Your Breath Away Here we have Iberostar, boldly wading into the azure waters of the Indian Ocean, planting its flag on the sandy beaches of Zanzibar. This isn’t just another notch on the resort’s belt—it’s their first time setting up shop in East Africa, a move ripe with promise and adventure both. A Suite So Sweet 358 suites, mind you. Each...

Continue Reading
Chaos Zero Nightmare's Award Is a Useful Signal for Games

Updated Category News Views 19

A story award can be easy to sneer at until a live-service game earns one across three markets. Smilegate's Chaos Zero Nightmare, a dark fantasy roguelike RPG developed by Super Creative, was named Best Story in Google Play's Best of 2026 awards for Taiwan, Hong Kong and Macau. That is not a sales figure, not a profit disclosure, and certainly not proof that a hit has...

Continue Reading
Inhibrx Ewing Data Gives Ozekibart a Real Clinical Signal

Updated Category News Views 131

Numbers this lopsided in relapsed Ewing sarcoma make me sit up straight, even after years of watching oncology releases try to turn every blip into a brass band. Inhibrx has reported updated Phase 1/2 data for ozekibart, paired with irinotecan and temozolomide, that look genuinely notable in a disease where patients have very few good cards left to play. That matters...

Continue Reading
Onward Therapeutics Secures $28M to Bolster Oncology R&D

Updated Category News Views 76

Cashing In to Conquer Cancer In the risk-laden world of biotech, Onward Therapeutics has just bagged a hefty NT$900 million—roughly US$28 million—from its Series B financing. That's not pocket change and speaks to the level of confidence their backers have, even as they plant their global headquarters firmly in Taipei since relocating from Switzerland. A Deep Dive...

Continue Reading
Philadelphia Firm Targets 100 Toys for Children This Holiday

Updated Category News Views 139

A hundred unopened toys can look modest on paper, yet that is exactly why this Philadelphia effort lands differently than the usual chest-thumping corporate charity chatter. van der Veen, Hartshorn & Levin has set a clear holiday target: collect 100 new, unwrapped toys for children in the Philadelphia area through the U.S. Marine Corps Reserve Toys for Tots program. No...

Continue Reading
LAFC Turns Empty Seats Into an AI Test Case for Sports

Updated Category News Views 72

Empty seats are a lousy kind of inventory A vacant stadium seat is perishable inventory with the clock screaming at it. LAFC and AccelerAI have aimed their first co-developed AI project at that unglamorous but important problem: getting more ticket holders through the gate without simply hacking prices down at the last minute. That is a far more sensible use of artificial...

Continue Reading
Benicia's Bold Move to Streamline Permitting Pays Off

Updated Category News Views 147

Award-Winning Innovation from Benicia Benicia, California, shoots ahead of the pack by scooping up a highly coveted Helen Putnam Award for Excellence. Why? They chopped down bureaucracy like a lumberjack with a new ax by ushering in a digital revolution for their permitting process. Make no mistake, folks, this ain’t just a pat on the back—it's a blueprint for cities...

Continue Reading
Apani Adds Kelsun Assets to Its Natural Fiber Platform

Updated Category News Views 141

A materials deal with more chemistry than chest-thumping Seaweed and cotton have landed under one roof, which is a lot more interesting than another apparel brand slapping a green label on ordinary fabric. Apani said November 17 it acquired the assets of Keel Labs, bringing Keel's seaweed-based Kelsun fiber alongside Apani's enhanced cotton-cellulose filament technology....

Continue Reading

Top 5 Most Recently Viewed Articles

Trinseo Announces New Dividend Amid Strategic Changes Ahead

Updated Category News Views 225

Trinseo Approves Dividend for Shareholders Trinseo (NYSE: TSE), a prominent provider of specialty material solutions, has recently announced a quarterly dividend approved by its Board of Directors. The dividend declared stands at $0.01 per share, set to be distributed on a future date, offering a slight financial incentive for shareholders. To be eligible, shareholders...

Continue Reading
2026 Mighty 25: Celebrating Military Community Leaders

Updated Category News Views 26

A Spotlight on Unsung Heroes Tampa, Florida, just got a little mightier as We Are The Mighty rolls out the red carpet for the 2026 Mighty 25. This annual roll call, backed by CareSource Military & Veterans™, shines a light on veterans, military spouses, creators, entrepreneurs, and change agents defying the status quo. They are redefining impact across the military...

Continue Reading
Rubrik Inc Soars as Earnings Beat Expectations

Updated Category News Views 238

Rubrik Inc's Recent Stock Surge Rubrik, Inc. (NYSE: RBRK) has recently captured the attention of the market as its shares have risen over 20% following an impressive report of fourth-quarter earnings. The company exceeded expectations in both profitability and revenue, which undoubtedly prompted a wave of investor optimism. Financial Performance Highlights For the latest...

Continue Reading
Sanofi’s Amlitelimab Achieves Key Study Goals for Eczema Treatment

Updated Category News Views 284

Sanofi’s Amlitelimab Revolutionizes Atopic Dermatitis Treatment In an exciting development for patients suffering from atopic dermatitis, Sanofi's amlitelimab has met all primary and key secondary endpoints in the pivotal COAST 1 phase 3 study, targeting both adults and adolescents. This innovative medication demonstrated meaningful efficacy in terms of skin clearance...

Continue Reading
Alphamin Resources Corp: Board Changes and Future Outlook

Updated Category News Views 168

Leadership Changes at Alphamin Resources Corp Alphamin Resources Corp., a prominent player in the mining sector, recently shared significant news regarding its board of directors. The company announced the resignation of Mr. Rudolf Pretorius as a director. This change marks a pivotal moment in the company’s leadership structure, as Mr. Pretorius had been with the board...

Continue Reading